Gardner Lewis Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-19,489
Closed -$1.82M 59
2023
Q3
$1.82M Buy
19,489
+1,387
+8% +$156K 0.63% 41
2023
Q2
$2.33M Hold
18,102
0.78% 37
2023
Q1
$2.1M Buy
18,102
+2,378
+15% +$266K 0.73% 39
2022
Q4
$1.78M Buy
+15,724
New +$1.73M 0.61% 41
2022
Q3
Sell
-52,516
Closed -$3.91M 73
2022
Q2
$3.91M Buy
52,516
+1,520
+3% +$139K 0.79% 41
2022
Q1
$6.52M Hold
50,996
1.17% 33
2021
Q4
$6.85M Sell
50,996
-548
-1% -$78.7K 1.27% 29
2021
Q3
$7.05M Sell
51,544
-3,680
-7% -$464K 1% 43
2021
Q2
$5.89M Hold
55,224
0.67% 43
2021
Q1
$4.96M Sell
55,224
-3,188
-5% -$299K 0.89% 45
2020
Q4
$5.4M Sell
58,412
-15,224
-21% -$1.36M 1.26% 31
2020
Q3
$7.59M Sell
73,636
-5,400
-7% -$564K 1.38% 26
2020
Q2
$8.01M Sell
79,036
-7,980
-9% -$714K 1.48% 23
2020
Q1
$5.86M Sell
87,016
-15,072
-15% -$938K 0.97% 28
2019
Q4
$5.58M Sell
102,088
-1,196
-1% -$56.7K 0.76% 38
2019
Q3
$3.85M Buy
103,284
+15,724
+18% +$611K 0.58% 44
2019
Q2
$3.28M Sell
87,560
-1,500
-2% -$47.1K 0.4% 48
2019
Q1
$2.65M Buy
+89,060
New +$3.13M 0.33% 51

Other funds holding DXCM